Literature DB >> 29936597

Community pharmacists' experiences and people at risk of suicide in Canada and Australia: a thematic analysis.

Andrea L Murphy1,2, Randa Ataya3, Dani Himmelman4, Claire O'Reilly5, Alan Rosen6,7, Luis Salvador-Carulla8, Ruth Martin-Misener9, Fred Burge10, Stanley Kutcher11,12, David M Gardner3,11.   

Abstract

PURPOSE: To explore Canadian and Australian community pharmacists' practice experiences in caring for people at risk of suicide.
METHODS: We conducted a thematic analysis of 176 responses to an open-ended extension question in an online survey.
RESULTS: Four themes were identified and include referrals and triage, accessibility for confiding, emotional toll, and stigma. Subthemes included gatekeeping the medication supply, sole disclosure, planning for end of life, concerns of support people, assessing the validity of suicidality, gaps in the system, not directly asking, ill-equipped, resources in the pharmacy, relying on others to continue care, and attention seeking.
CONCLUSIONS: Community pharmacists are caring for patients at risk of suicide frequently, and often with patients seeking the help of pharmacists directly. Pharmacists engage in activities and actions that would be considered outside of the traditional dispensing roles and provide support and intervention to people at risk of suicide through collaboration and other mechanisms. Further research to determine appropriate education and training and postvention supports is required.

Entities:  

Keywords:  Medications; Mental disorders; Pharmaceutical services; Pharmacists; Suicide

Mesh:

Year:  2018        PMID: 29936597     DOI: 10.1007/s00127-018-1553-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  44 in total

1.  Development of a questionnaire on attitudes towards suicide (ATTS) and its application in a Swedish population.

Authors:  Ellinor Salander Renberg; Lars Jacobsson
Journal:  Suicide Life Threat Behav       Date:  2003

2.  Community Pharmacy Practice Barriers in Preventing Drug Misuse, Divergence and Overdose: A Focus Group Study.

Authors:  Christine Leong; Jitender Sareen; Murray W Enns; James Bolton; Silvia Alessi-Severini
Journal:  Healthc Q       Date:  2015

3.  A feasibility study of community pharmacists performing depression screening services.

Authors:  Claire L O'Reilly; Eling Wong; Timothy F Chen
Journal:  Res Social Adm Pharm       Date:  2014-09-28

4.  The geographic accessibility of pharmacies in Nova Scotia.

Authors:  Michael R Law; Deborah Heard; Judith Fisher; Jay Douillard; Greg Muzika; Ingrid S Sketris
Journal:  Can Pharm J (Ott)       Date:  2013-01

5.  Have broad-based community and professional education programs influenced mental health literacy and treatment seeking of those with major depression and suicidal ideation?

Authors:  Robert D Goldney; Laura J Fisher
Journal:  Suicide Life Threat Behav       Date:  2008-04

6.  Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.

Authors:  Shelly Rosser; Stacey Frede; Wayne F Conrad; Pamela C Heaton
Journal:  J Am Pharm Assoc (2003)       Date:  2013 Jan-Feb

Review 7.  Evaluating the impact of pharmacists in mental health: a systematic review.

Authors:  Patrick R Finley; M Lynn Crismon; A John Rush
Journal:  Pharmacotherapy       Date:  2003-12       Impact factor: 4.705

8.  Exploring general practitioners' views and experiences on suicide risk assessment and management of young people in primary care: a qualitative study in the UK.

Authors:  Maria Michail; Lynda Tait
Journal:  BMJ Open       Date:  2016-01-12       Impact factor: 2.692

9.  Incidence, clinical management, and mortality risk following self harm among children and adolescents: cohort study in primary care.

Authors:  Catharine Morgan; Roger T Webb; Matthew J Carr; Evangelos Kontopantelis; Jonathan Green; Carolyn A Chew-Graham; Nav Kapur; Darren M Ashcroft
Journal:  BMJ       Date:  2017-10-18

Review 10.  Patient-centred access to health care: conceptualising access at the interface of health systems and populations.

Authors:  Jean-Frederic Levesque; Mark F Harris; Grant Russell
Journal:  Int J Equity Health       Date:  2013-03-11
View more
  8 in total

1.  The clinical impact of pharmacist services on mental health collaborative teams: A systematic review.

Authors:  Brandy Davis; Jingjing Qian; Surachat Ngorsuraches; Ruth Jeminiwa; Kimberly B Garza
Journal:  J Am Pharm Assoc (2003)       Date:  2020-06-27

2.  Pharmacists and their role in managing mental illness.

Authors:  Malak Al-Ali
Journal:  Can Pharm J (Ott)       Date:  2020-10-21

3.  Student pharmacist personal and work experiences with people displaying warning signs of suicidal ideation.

Authors:  Matthew Witry; Alyssa Clayden
Journal:  Ment Health Clin       Date:  2020-07-02

4.  A survey of Canadian and Australian pharmacists' stigma of suicide.

Authors:  Andrea L Murphy; Claire L O'Reilly; Randa Ataya; Steve P Doucette; Ruth Martin-Misener; Alan Rosen; David M Gardner
Journal:  SAGE Open Med       Date:  2019-01-14

5.  Pharmacists' acceptability of a men's mental health promotion program using the Theoretical Framework of Acceptability.

Authors:  Andrea Lynn Murphy; David Martin Gardner
Journal:  AIMS Public Health       Date:  2019-06-27

6.  Evaluation of participant reluctance, confidence, and self-reported behaviors since being trained in a pharmacy Mental Health First Aid initiative.

Authors:  Matthew Witry; Hacer Karamese; Anthony Pudlo
Journal:  PLoS One       Date:  2020-05-04       Impact factor: 3.240

7.  Suicide Prevention in Nigeria: Can Community Pharmacists Have a Role?

Authors:  Somto Chike-Obuekwe; Nicola J Gray; Hayley C Gorton
Journal:  Pharmacy (Basel)       Date:  2022-09-02

8.  Current and potential contributions of community pharmacy teams to self-harm and suicide prevention: A qualitative interview study.

Authors:  Hayley C Gorton; Donna Littlewood; Christine Lotfallah; Matthew Spreadbury; Kai Ling Wong; Patricia Gooding; Darren M Ashcroft
Journal:  PLoS One       Date:  2019-09-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.